Research ArticleOpen AccessGoogle Scholar indexed
Saudi Scientific Diabetes Society Position Statement: Management of Diabetes Mellitus in the Pandemic of COVID-19
Medicine Department, King Abdulaziz University, Jeddah, KSA
Endocrinology Department, Alhada Armed Forces Hospital, Taif, KSA
Independent Researcher, Cairo, Egypt
Medicine Department, King Abdulaziz University, Jeddah, KSA
Independent Researcher, Cairo, Egypt
Independent Researcher, Cairo, Egypt
Independent Researcher, Cairo, Egypt
- 1 Medicine Department, King Abdulaziz University, Jeddah, KSA
- 2 Endocrinology Department, Alhada Armed Forces Hospital, Taif, KSA
- 3 Independent Researcher, Cairo, Egypt
- 4 Medicine Department, King Abdulaziz University, Jeddah, KSA
- 5 Independent Researcher, Cairo, Egypt
- 6 Independent Researcher, Cairo, Egypt
- 7 Independent Researcher, Cairo, Egypt
International Journal of Clinical Medicine·Volume 11 (2020)·Pages 199–206·Published 27 April 2020·DOI10.4236/ijcm.2020.115020
Copy link · social · email
Abstract
About 10% coronavirus (COVID-19) infected patients are with diabetes comorbidity. Also, diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significant mortality in those people with COVID-19. In this position statement, the management of diabetes in cases of COVID-19, has been presented. The impact of diabetes on the morbidity and mortality of COVID-19, as well as both the target glucose level and the method of blood glucose control have been presented in details.
KeywordsCOVID-19Diabetes MellitusGlycemic TargetBlood Glucose Control
- WHO (2020) Coronavirus Disease (COVID-2019) Situation Report-77. https://www.who.int/docs/default-source/coronaviruse/situation-reports /20200406-sitrep-77-covid-19.pdf?sfvrsn=21d1e632_2
- Guan, W.-J., Ni, Z., Hu, Y., Liang, W., Ou, C.-Q., He, J., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. https://doi.org/10.1101/2020.02.06.20020974
- Guan, W.-J., Liang, W.-H., Zhao, Y., et al. (2020) Comorbidity and Its Impact on 1590 Patients with Covid-19 in China: A Nationwide Analysis. European Respiratory Society (In Press). https://doi.org/10.1183/13993003.00547-2020
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) (2020).
- The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China, 2020. China CDC Weekly, 2, 113-122.
- Zhang, B., Zhou, X., Qiu, Y., Feng, F., Feng, J., Jia, Y., et al. (2020) Clinical Characteristics of 82 Death Cases with COVID-19. medRxiv. https://doi.org/10.1101/2020.02.26.20028191
- Fadaei, R., Bagheri, N., Heidarian, E., Nouri, A., Hesari, Z., Moradi, N., et al. (2020) Serum Levels of IL-32 in Patients with Type 2 Diabetes Mellitus and Its Relationship with TNF-α and IL-6. Cytokine, 125, Article ID: 154832. https://doi.org/10.1016/j.cyto.2019.154832
- Nielsen, T.B., Pantapalangkoor, P., Yan, J., Luna, B.M., Dekitani, K., Bruhn, K., et al. (2017) Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE. mBio, 8, e00818. https://doi.org/10.1128/mBio.00818-17
- Totura, A.L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M.G., Heise, M.T., et al. (2015) Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection. mBio, 6, e00638. https://mbio.asm.org/content/6/3/e00638-15
- Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. The Lancet, 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
- Yang, J.-K., et al. (2010) Binding of SARS Coronavirus to Its Receptor Damages Islets and Causes Acute Diabetes. Acta Diabetologica, 47, 193-199. https://doi.org/10.1007/s00592-009-0109-4